Compare AU
Compare MVS vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Aussie Small-Cap Dividends (MVS) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
MVS | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 8 | 238 |
Median incremental investment | $993.50 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $979.11 | $1,811.38 |
Average age group | > 35 | 26 - 35 |
Key Summary
MVS | IXJ | |
|---|---|---|
Strategy | MVS.AX was created on 2015-05-26 by VanEck. The fund's investment portfolio concentrates primarily on small cap equity. The Fund gives investors exposure to a portfolio that only includes the most liquid small-cap ASX-listed companies that generate revenues in Australia and did not omit their latest dividend payment. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Pinnacle Investment Management Group Ltd (2.46 %) Gold Road Resources Ltd (2.46 %) Genesis Minerals Ltd (2.32 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Financials (50.99 %) Materials (30.51 %) Consumer Discretionary (18.50 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | Australia (99.99 %) | United States (99.97 %) |
Management fee | 0.49 % | 0.46 % |
Key Summary
MVS | IXJ | |
|---|---|---|
Issuer | VanEck | iShares |
Tracking index | MVIS Australia Small-Cap Dividend Payers Index - AUD | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.49 % | 0.46 % |
Price | $19.78 | $144.91 |
Size | $164.285 million | $1.407 billion |
10Y return | N/A | 119.31 % |
Annual distribution yield (5Y) | 4.86 % | 1.26 % |
Market | ASX | ASX |
First listed date | 28/05/2015 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
MVS | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 8 | 238 |
Median incremental investment | $993.50 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $979.11 | $1,811.38 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
MVS | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
MVS | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |